WE ARE

A pharmaceutical company specialized in high quality

ONCOLOGY PRODUCTS

 

ABOUT US

MANUFACTURING EXCELLENCE 

CURRENT ONCOLOGY REVIEW

MAGAZINE

10/20/2020

Spending the cost of Bortezomib ACTe launch for the first injection of patients in need.

Considering the current situation in the country and taking into account the needs of patients, Actero Company decided to spend all the costs related to the unveiling of the drug Bortezomib ACTe on the first free injection of patients’ candidates receiving Bortezomib. »MORE

10/20/2020

Breast Cancer Webinar

Simultaneously with the unveiling of Onkotaxel (Docetaxel of Actero Company), a subspecialized webinar was held on July 23rd with the presence of Dr. Safa Najafi (Medical Oncologist), Dr. Samiei (Radiotherapy Oncologist), Dr. Azimi Nejadan (Surgeon) and Ms. Dr. Ehsani (Pathologist) on August 2.»MORE

PRODUCTS

We are building a unique range of products to cover the needs of cancer patients. Actero is not only focused on chemotherapy, but understands cancer treatment as a whole. That is why we invest in high quality oncology drugs, as well as in palliative care»MORE

RESPONSIBILITY

We understand that pharmaceutical industry is not comparable to other industries. That is why ethical behavior is at the heart of our business.

» MORE